Im vergangenen Jahr erzielte Retractable Technologies Inc für sein leistungsstärkstes Segment, Syringes, Einnahmen von 24.91M USD. Die Region United States leistete den größten Beitrag mit 32.24M USD im letzten Jahr. Im letzten Quartal berichtete Retractable Technologies Inc über Einnahmen in Höhe von 6.25M USD für den Zeitraum bis zum 2026-06-30, die aus dem leistungsstärksten Segment, Syringes, stammten. United States trug mit 5.87M USD den höchsten Umsatz bei.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Syringes

EasyPoint Needles

Blood Cllection Products

Other Products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Syringes

24.91M(65.10%)

22.63M(68.47%)

34.16M(78.34%)

86.74M(91.48%)

176.33M(93.60%)

68.73M(83.96%)

35.64M(85.27%)

28.27M(84.95%)

EasyPoint Needles

11.94M(31.21%)

8.95M(27.08%)

7.25M(16.63%)

4.67M(4.93%)

9.64M(5.12%)

9.63M(11.76%)

2.98M(7.13%)

3.41M(10.26%)

Blood Cllection Products

1.37M(3.58%)

1.43M(4.31%)

1.93M(4.42%)

2.95M(3.12%)

2.25M(1.19%)

2.36M(2.89%)

2.72M(6.50%)

1.42M(4.28%)

Other Products

43.63K(0.11%)

45.85K(0.14%)

266.27K(0.61%)

451.95K(0.48%)

167.56K(0.09%)

1.14M(1.39%)

464.05K(1.11%)

172.41K(0.52%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

United States

North and South America(excluding U.S)

Other International

Sales to U.S. government

HHS Order sales to U.S. Government

North and South America sales

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

32.24M(84.24%)

29.37M(88.88%)

34.60M(79.36%)

36.49M(38.49%)

53.89M(28.61%)

42.17M(51.51%)

31.90M(76.32%)

28.65M(86.09%)

27.02M(78.32%)

26.31M(88.20%)

23.03M(77.93%)

27.65M(80.10%)

24.84M(80.70%)

25.36M(75.39%)

26.66M(83.03%)

North and South America(excluding U.S)

5.06M(13.22%)

1.96M(5.93%)

6.09M(13.96%)

29.13M(30.72%)

14.56M(7.73%)

6.89M(8.42%)

8.25M(19.74%)

3.60M(10.81%)

--(--)

Other International

968.61K(2.53%)

1.71M(5.19%)

2.91M(6.68%)

13.47M(14.20%)

6.27M(3.33%)

1.17M(1.42%)

1.65M(3.95%)

1.03M(3.10%)

1.10M(3.18%)

776.87K(2.60%)

853.44K(2.89%)

1.22M(3.53%)

1.49M(4.84%)

3.61M(10.74%)

710.16K(2.21%)

Sales to U.S. government

--(--)

15.73M(16.59%)

113.66M(60.34%)

--(--)

HHS Order sales to U.S. Government

--(--)

31.63M(38.64%)

--(--)

North and South America sales

--(--)

6.38M(18.50%)

2.74M(9.19%)

5.67M(19.18%)

5.65M(16.37%)

4.45M(14.47%)

4.67M(13.88%)

4.74M(14.75%)